產(chǎn)品供應(yīng)人參皂苷Rb1

  • 發(fā)布日期：2024-09-02
  • 有效期限：30天
陜西萃康醫(yī)藥科技有限公司 VIP
255-532-8
C54H92O23
1109.2945
回上一頁 在線詢盤 打印本頁
詳細(xì)信息
  • ;人參皂甙 Rb1;人參皂苷Rb1;人參皂甙Rb1;
  • ginsenoside rb1
  • ;Sanchinoside E1;Arasaponin E1;GRb 1;Gynosaponin C;Gypenoside III;NSC 310103;Panax saponin E;Pseudoginsenoside D;2-O-beta-Glucopyranosyl-(3beta,12beta)-20-((6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy)-12-hydroxydammar-24-en-3-yl-beta-D-glucopyranoside;beta-D-Glucopyranoside, (3-beta,12-beta)-20-((6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy)-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-;20-[(6-O-hexopyranosylhexopyranosyl)oxy]-12-hydroxydammar-24-en-3-yl 2-O-hexopyranosylhexopyranoside;(2S,3R,4S,5S,6R)-2-[1-[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-3-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy-12-hydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1,5-dimethyl-hex-4-enoxy]-6-[[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-3,4,5-triol;
  • InChI=1/C54H92O23/c1-23(2)10-9-14-54(8,77-48-44(69)40(65)37(62)29(74-48)22-70-46-42(67)38(63)34(59)26(19-55)71-46)24-11-16-53(7)33(24)25(58)18-31-51(5)15-13-32(50(3,4)30(51)12-17-52(31,53)6)75-49-45(41(66)36(61)28(21-57)73-49)76-47-43(68)39(64)35(60)27(20-56)72-47/h10,24-49,55-69H,9,11-22H2,1-8H3/t24-,25+,26+,27+,28+,29+,30-,31+,32-,33-,34+,35+,36+,37+,38-,39-,40-,41-,42+,43+,44+,45+,46?,47-,48-,49-,51-,52+,53+,54?/m0/s1
  • 1.44g/cm3
  • 1146°C at 760 mmHg
  • 646.8°C
  • CAS NO：41753-43-9

免責(zé)聲明：以上所展示的信息由企業(yè)自行提供，內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由發(fā)布企業(yè)負(fù)責(zé)，化工網(wǎng)對此不承擔(dān)任何保證責(zé)任。我們原則上建議您選擇化工網(wǎng)高級會員或VIP會員。